364 related articles for article (PubMed ID: 31784574)
21. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
22. Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.
Gandaglia G; Zaffuto E; Fossati N; Bandini M; Suardi N; Mazzone E; Dell'Oglio P; Stabile A; Freschi M; Montorsi F; Briganti A
BJU Int; 2018 Mar; 121(3):421-427. PubMed ID: 29063734
[TBL] [Abstract][Full Text] [Related]
23. Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.
Abdollah F; Klett DE; Sammon JD; Dalela D; Sood A; Hsu L; Diaz M; Gupta N; Peabody JO; Trinh QD; Menon M
Can J Urol; 2016 Feb; 23(1):8141-50. PubMed ID: 26892054
[TBL] [Abstract][Full Text] [Related]
24. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
[TBL] [Abstract][Full Text] [Related]
25. Radical Prostatectomy and Pelvic Lymph Node Dissection in Kaiser Permanente Southern California: 15-Year Experience.
Banapour P; Schumacher A; Lin JC; Finley DS
Perm J; 2019; 23():. PubMed ID: 30939263
[TBL] [Abstract][Full Text] [Related]
26. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.
Briganti A; Karnes JR; Da Pozzo LF; Cozzarini C; Gallina A; Suardi N; Bianchi M; Freschi M; Doglioni C; Fazio F; Rigatti P; Montorsi F; Blute ML
Eur Urol; 2009 Feb; 55(2):261-70. PubMed ID: 18838212
[TBL] [Abstract][Full Text] [Related]
27. External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy.
Dell'Oglio P; Abdollah F; Suardi N; Gallina A; Cucchiara V; Vizziello D; Zaffuto E; Cantiello F; Damiano R; Shariat S; Montorsi F; Briganti A
J Endourol; 2014 Apr; 28(4):416-23. PubMed ID: 24188052
[TBL] [Abstract][Full Text] [Related]
28. Indications for pelvic nodal treatment in prostate cancer should change. Validation of the Roach formula in a large extended nodal dissection series.
Abdollah F; Cozzarini C; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Salonia A; La Macchia M; Di Muzio N; Rigatti P; Montorsi F; Briganti A
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):624-9. PubMed ID: 22099031
[TBL] [Abstract][Full Text] [Related]
29. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
[TBL] [Abstract][Full Text] [Related]
30. The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
Doan P; Katelaris A; Scheltema MJ; Hayen A; Amin A; Siriwardana A; Tran M; Geboers B; Gondoputro W; Haynes AM; Matthews J; Delprado W; Stricker PD; Thompson J
BMC Urol; 2023 Apr; 23(1):68. PubMed ID: 37118731
[TBL] [Abstract][Full Text] [Related]
31. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
[TBL] [Abstract][Full Text] [Related]
32. Benefit and harm of lymphadenectomy in intermediate risk prostate cancer: comparison of five nomograms.
Lodeta B; Baric H; Hatz D; Jozipovic D; Augustin H
BMC Urol; 2023 Nov; 23(1):190. PubMed ID: 37980520
[TBL] [Abstract][Full Text] [Related]
33. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases.
Maccio L; Barresi V; Domati F; Martorana E; Cesinaro AM; Migaldi M; Iachetta F; Ieni A; Bonetti LR
Intern Emerg Med; 2016 Apr; 11(3):399-404. PubMed ID: 26875178
[TBL] [Abstract][Full Text] [Related]
35. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.
Gandaglia G; Trinh QD; Hu JC; Schiffmann J; Becker A; Roghmann F; Popa I; Tian Z; Perrotte P; Montorsi F; Briganti A; Karakiewicz PI; Sun M; Abdollah F
Eur J Surg Oncol; 2014 Sep; 40(9):1080-6. PubMed ID: 24411705
[TBL] [Abstract][Full Text] [Related]
36. Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
Schmitges J; Karakiewicz PI; Sun M; Abdollah F; Budäus L; Isbarn H; Bianchi M; Trinh QD; Schlomm T; Chun FK; Graefen M; Steuber T
Eur J Surg Oncol; 2012 Jul; 38(7):624-9. PubMed ID: 22531769
[TBL] [Abstract][Full Text] [Related]
37. Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?
Touijer K; Fuenzalida RP; Rabbani F; Paparel P; Nogueira L; Cronin AM; Fine SW; Guillonneau B
BJU Int; 2011 Aug; 108(3):372-7. PubMed ID: 21199284
[TBL] [Abstract][Full Text] [Related]
38. Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques.
Yaxley JW; Dagher J; Delahunt B; Egevad L; Srigley J; Samaratunga H
World J Urol; 2018 Jan; 36(1):15-20. PubMed ID: 29116393
[TBL] [Abstract][Full Text] [Related]
39. Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5.
Porpiglia F; Manfredi M; Mele F; Bertolo R; Bollito E; Gned D; De Pascale A; Russo F; Passera R; Fiori C; De Luca S
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):85-91. PubMed ID: 29472629
[TBL] [Abstract][Full Text] [Related]
40. Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer.
Guo XX; Guo RQ; Hou HM; Wang X; Wang JY; Liu M
Int J Clin Oncol; 2020 Dec; 25(12):2115-2121. PubMed ID: 32748296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
